Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 45.15M
March 31, 2026 48.40M
December 31, 2025 51.87M
September 30, 2025 56.15M
June 30, 2025 60.25M
March 31, 2025 60.99M
December 31, 2024 60.30M
September 30, 2024 69.58M
June 30, 2024 70.32M
March 31, 2024 70.51M
December 31, 2023 71.56M
September 30, 2023 81.51M
June 30, 2023 104.40M
March 31, 2023 104.56M
December 31, 2022 96.55M
September 30, 2022 91.08M
June 30, 2022 86.63M
March 31, 2022 82.92M
December 31, 2021 75.59M
September 30, 2021 74.59M
June 30, 2021 63.07M
March 31, 2021 53.00M
December 31, 2020 23.40M
September 30, 2020 15.40M
June 30, 2020 10.86M
Date Value
March 31, 2020 6.995M
December 31, 2019 6.882M
September 30, 2019 81.94M
June 30, 2019 82.00M
March 31, 2019 65.81M
December 31, 2018 61.98M
September 30, 2018 36.61M
June 30, 2018 21.68M
March 31, 2018 10.58M
December 31, 2017 10.86M
September 30, 2017 7.375M
June 30, 2017 4.637M
March 31, 2017 0.2169M
December 31, 2016 -1.083M
September 30, 2016 -1.805M
June 30, 2016 -1.808M
March 31, 2016 -1.700M
December 31, 2015 -1.961M
September 30, 2015 -1.345M
June 30, 2015 -1.803M
March 31, 2015 -1.530M
December 31, 2014 -1.685M
September 30, 2014 1.832M
June 30, 2014 -1.204M
March 31, 2014 -1.109M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Omeros Corp. -51.35M
Talphera, Inc. 14.41M
Hyperion DeFi, Inc. 101.93M
Atea Pharmaceuticals, Inc. 204.16M
Cencora, Inc. 3.051B

Shareholders Equity (Quarterly) Related Metrics